title: Packaging BCG: standardizing an anti-tuberculosis vaccine in interwar Europe.
abstract: Using the example of the anti-tuberculosis vaccine BCG during the 1920s and 1930s, this article asks how a labile laboratory-modified bacteria was transformed into a genuine standard vaccine packaged and commercialized as a pharmaceutical product. At the center of the analysis lies the notion of standardization inquiring why and how a local laboratory process with standard operating procedures (SOPs) reached its limits and was transformed when the product faced international distribution. Moving from Paul Ehrlich's initial technological notion of Wertbestimmung referring to a practice physiologically testing the effects of ill-defined antitoxins, the concept of standardization is extended to pharmaceutical and economical meanings implying quality control for biological therapeutic agents produced by a variety of industrial entrepreneurs. Following the request for product uniformity, two ways to maintain levels of compatibility and commonality are depicted opposing SOPs and end-product control. Furthermore, standardization is understood as a spiral, never ending process where progressive transformation of the vaccine in its production and medical uses periodically recreated the necessity of standardization. Developments analyzed are thus understood as a stabilization process aligning laboratory settings, products, and practices with medical theories and practices through technical, bureaucratic, and organizational systems. A paradox of the analysis is that standardization as a historical phenomenon and moment in the history of drug development was initially linked to a problem of under-determination of what was to be standardized and to a knowledge gap before it could become a central concept for quality control.
authors.affiliation: Université Louis Pasteur, Strasbourg, France.
authors.forename: Christian
authors.initials: C
authors.lastname: Bonah
mesh_terms: D000818:Animals; D001500:BCG Vaccine / Q000266:history* / Q000592:standards; D001681:Biological Assay / Q000266:history; D004349:Drug Packaging / Q000266:history*; D005060:Europe; D049673:History, 20th Century; D006801:Humans; D014376:Tuberculosis / Q000266:history* / Q000517:prevention & control
chemical_list: D001500:BCG Vaccine